These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10541301)

  • 61. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines.
    Szotowski B; Antoniak S; Poller W; Schultheiss HP; Rauch U
    Circ Res; 2005 Jun; 96(12):1233-9. PubMed ID: 15920023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells.
    Kim I; Oh JL; Ryu YS; So JN; Sessa WC; Walsh K; Koh GY
    FASEB J; 2002 Jan; 16(1):126-8. PubMed ID: 11729102
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
    Bajaj MS; Ghosh M; Bajaj SP
    J Thromb Haemost; 2007 Jul; 5(7):1493-9. PubMed ID: 17470199
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effects of citrate dialysate in hemodialysis on polymorphonuclear elastase interaction with tissue factor and its inhibitor.
    Li J; Sun S; Han M; Wang L; Liao R; Xiong Y; Li Y; Jiang H; Qin Z; Maharjan A; Cozzolino M; Zarbock A; Su B
    Ann Transl Med; 2019 Aug; 7(16):391. PubMed ID: 31555705
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation.
    Napoleone E; Di Santo A; Bastone A; Peri G; Mantovani A; de Gaetano G; Donati MB; Lorenzet R
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):782-7. PubMed ID: 12006390
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K; Takeya M; Ogawa H; Suefuji H; Yasue H; Takahashi K
    J Pathol; 1999 Jun; 188(2):180-8. PubMed ID: 10398162
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells.
    Okamoto T; Akita N; Hayashi T; Shimaoka M; Suzuki K
    Atherosclerosis; 2014 Oct; 236(2):430-7. PubMed ID: 25171777
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of cinnamic acid on expression of tissue factor induced by TNFalpha in endothelial cells and its mechanisms.
    Li X; Wen Z; He X; He S
    J Chin Med Assoc; 2006 May; 69(5):207-12. PubMed ID: 16835982
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes.
    Bajaj MS; Steer S; Kuppuswamy MN; Kisiel W; Bajaj SP
    Thromb Haemost; 1999 Dec; 82(6):1663-72. PubMed ID: 10613653
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide.
    Nguyên P; Broussas M; Cornillet-Lefèbvre P; Potron G
    Transfusion; 1999 Sep; 39(9):975-82. PubMed ID: 10533824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. C5a induces tissue factor activity on endothelial cells.
    Ikeda K; Nagasawa K; Horiuchi T; Tsuru T; Nishizaka H; Niho Y
    Thromb Haemost; 1997 Feb; 77(2):394-8. PubMed ID: 9157602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The functional expression of tissue factor by fibroblasts and endothelial cells under flow conditions.
    Grabowski EF; Zuckerman DB; Nemerson Y
    Blood; 1993 Jun; 81(12):3265-70. PubMed ID: 8507863
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients.
    McKenna RM; Macdonald C; Bernstein KN; Rush DN
    Nephron; 1994; 67(2):190-6. PubMed ID: 8072608
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor.
    Cimmino G; Cirillo P; Ragni M; Conte S; Uccello G; Golino P
    J Thromb Thrombolysis; 2015 Aug; 40(2):186-92. PubMed ID: 25712553
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor.
    Røttingen JA; Enden T; Camerer E; Iversen JG; Prydz H
    J Biol Chem; 1995 Mar; 270(9):4650-60. PubMed ID: 7876236
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-α, interleukin (IL)-33 or IL-1β.
    Kamegashira A; Yanase Y; Takahagi S; Saito R; Uchida K; Kawaguchi T; Ishii K; Tanaka A; Ozawa K; Hide M
    J Dermatol; 2020 Nov; 47(11):1293-1300. PubMed ID: 32748974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Tissue factor and tissue factor pathway inhibitor in peritonitis treated with dialysis].
    Małyszko J; Małyszko J; Myśliwiec M
    Przegl Lek; 2000; 57(7-8):374-7. PubMed ID: 11109307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.